Medtronic plc
Medtronic plc
Your view on MDT
Overview
What the company does, where it operates, and who runs it.
About Medtronic plc
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Geoffrey Straub Martha
- Headquarters
- 20 On Hatch, Galway, IE
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Geoffrey Straub Martha
- Headquarters
- 20 On Hatch, Galway, IE
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide.
Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products.
The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease.
Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments.
It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain.
The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Stock Data
Price chart, volume, and trading data.
What moved it
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Medtronic plc from FRC's valuation model, read against the market price. MDT last traded at $102.88, 25.3× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Medtronic plc. Starting points for Medtronic plc: P/E 25.3, EPS $4.09, beta 0.57 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Medtronic plc. Medtronic plc paid $2.86 per share over the last year — a 2.8% yield at the current $102.88 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Medtronic plc. Trailing twelve-month EPS for Medtronic plc stands at $4.09. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.
Current price
—
live quote
Analysts' target
$101.76
average of 17 firms, last 12 months
Analyst Ratings
- Strong Buy0
- Buy16
- Hold6
- Sell0
- Strong Sell0
Earnings Estimate
| EPS | Current QtrOct 2026 | Next QtrJan 2027 | Current YearFY Apr 2027 | Next YearFY Apr 2028 |
|---|---|---|---|---|
| Avg. estimate | $1.33 | $1.43 | $5.98 | $6.40 |
| Low estimate | $1.31 | $1.41 | $5.96 | $6.28 |
| High estimate | $1.40 | $1.45 | $6.00 | $6.55 |
| No. of analysts | 16 | 16 | 17 | 17 |
| Year-ago EPS | $1.36 | $1.36 | $3.73 | — |
| Growth | -1.9% | +4.8% | +60.2% | — |
Revenue Estimate
| Revenue | Current QtrOct 2026 | Next QtrJan 2027 | Current YearFY Apr 2027 | Next YearFY Apr 2028 |
|---|---|---|---|---|
| Avg. estimate | $9.48B | $9.52B | $39.05B | $40.28B |
| Low estimate | $9.41B | $9.43B | $38.82B | $36.90B |
| High estimate | $9.55B | $9.56B | $39.15B | $41.02B |
| No. of analysts | 15 | 15 | 21 | 21 |
| Year-ago revenue | $8.96B | $9.02B | $36.36B | — |
| Growth | +5.8% | +5.6% | +7.4% | — |
Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga, Pulse 2.0, Investing; as of Nov 18, 2026. Not FRC research or a recommendation.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Medtronic plc. Medtronic plc has reported as a listed company since 1973. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Peer companies
Market cap
- AVRAnteris Technologies Global Corp.Medical - Devices$556M
- BSXBoston Scientific CorporationMedical - Devices$63.3B
- EWEdwards Lifesciences CorporationMedical - Devices$61.6B
- GNGBYGetinge AB (publ)Medical - Devices$6.1B
- LIVNLivaNova PLCMedical - Devices$5.1B
- PENPenumbra, Inc.Medical - Devices$12.6B
- PHGKoninklijke Philips N.V.Medical - Devices$29.3B
More Medical - Devices companies
- AMBBYAmbu A/SOTC$3.3B
- AMBFFAmbu A/SOTC$3.7B
- AMIXAutonomix Medical, Inc. Common StockNASDAQ$597,632
- AORTArtivion, Inc.NYSE$901M
- AQQRFAquarius Surgical Technologies Inc.OTC$115,917
ETFs holding Medtronic plc
% of the fund
- VOOVanguard S&P 500 ETF$1.0T in assets0.18%
- VTIVanguard Total Stock Market ETF$689.2B in assets0.16%
- IVViShares Core SP 500 ETF$852.9B in assets0.20%
- SPYState Street SPDR S&P 500 ETF Trust$818.5B in assets0.20%
- IHIiShares US Medical Devices ETF$4.0B in assets11.77%
- HHL.TOHarvest Healthcare Leaders Income ETF$2.2B in assets4.86%
- FDLFirst Trust Morningstar Dividend Leaders Index Fund$8.4B in assets2.53%
- GCOWPacer Global Cash Cows Dividend ETF$3.7B in assets2.37%
Largest holders first, then the funds most concentrated in MDT.
Institutional Ownership
Which funds and firms own the stock.
About this section
Which institutions hold Medtronic plc, and how their positions are changing. At a $131.60B market value, institutional positions materially move Medtronic plc's register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Medtronic plc executives and directors. Shares of Medtronic plc have traded between $79.29 and $102.48 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
Senate Trading
U.S. Senator disclosures filed under the STOCK Act.
About this section
U.S. Senate disclosures naming Medtronic plc. Medtronic plc is a $131.60B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.
House Trading
U.S. Representative disclosures filed under the STOCK Act.
About this section
U.S. House of Representatives disclosures naming Medtronic plc. Representatives' reported transactions in this security, shown next to the company's fundamentals.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Medtronic plc. Coverage tracks Medtronic plc within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Medtronic plc.